Popular Articles

Unique Cardiovascular Treatment Readied For Global Market: Proprietary Paccocath(R) Technology Is The Only Drug Eluting Balloon With Clinical Data
MEDRAD Interventional(TM)/Possis(R) announced that it has reached key milestones in bringing the Paccocath(R) Technology closer to market as an option for the over 14 million patients in the United States and Europe who suffer from Peripheral Arterial Disease (PAD). These milestones include the selection of physician investigators for U.S. clinical trials and the completion of a new state-of-the-art manufacturing facility.
buy viagra
The Importance Of Medicaid Continuity For Former Inmates
It is time for states to suspend, rather than terminate, the Medicaid benefits of inmates while they are incarcerated, say correctional health care experts from The Miriam Hospital in a commentary published online by the Journal of General Internal Medicine.
News of the day
Breast Cancer Radiation Guidelines Called Positive Step
The new medical consensus statement on accelerated partial breast irradiation is an important step toward defining patient selection criteria and highlights the importance of targeting radiation, said two of the nation"s leading APBI physicians.
Endocrinology

Three New Studies Give Clear Guidance On How To Better Recruit Volunteers For Alzheimer's Clinical Studies

Partnering with local physicians, working with local clinics, conducting educational seminars and health fairs were found to be the most effective tools in recruiting people for clinical studies "Clinical trials are very important. Not only do they drive forward dementia research but people who participate in clinical trials often experience positive benefits. Despite this a very small number of people are given the opportunity to participate in a dementia research trial. We must invest in clinical trials and use the unique value of the NHS to improve patient access to clinical trials. This will allow new treatments to reach people with dementia as soon as possible. "Communication is also key. It is important to ensure that people are given practical information about available trials and realistic advice about selection." Professor Clive Ballard Director of Research Alzheimer"s Society Notes - International Conference of Alzheimer"s Disease runs from 11 - 16 July 2009 for further information please visit ICAD - One in three people over 65 will die with dementia - Alzheimer"s Society research shows that 700,000 people in the UK have a form of dementia, more than half have Alzheimer"s disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051. - Alzheimer"s Society champions the rights of people living with dementia and the millions of people who care for them. - Alzheimer"s Society works in England, Wales and Northern Ireland - Alzheimer"s Society needs to raise money to help people live well with dementia today and for research to find a cure for tomorrow. You can donate now by calling 0845 306 0898 or visiting http://www.alzheimers.org.uk Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):